Supporting Breakthroughs in Autoimmune Disease Research at Pharmidex
January 19, 2026

Pharmidex is proud to offer comprehensive in vitro and preclinical solutions tailored to autoimmune disease research, helping accelerate the development of novel treatments.


Our expertise spans multiple autoimmune indications including multiple sclerosis, psoriasis, atopic dermatitis, alopecia, colitis, immune response and vitiligo, combining rigorous proof-of-concept studies with integrated pharmacokinetic, pharmacodynamic, biomarkers analysis, histopathological evaluation of relevant organs and tissues, toxicological and bioanalytical endpoints to support fast-track research.


With deep scientific knowledge and flexible study designs, we partner with researchers to deliver translationally relevant data that informs confident decision-making throughout the drug discovery and development pathway.


If your team is advancing immune-modulating therapies, we’d be delighted to discuss how Pharmidex can help support your research.


🌐 www.pharmidex.com

April 20, 2026
Pharmidex is pleased to announce that Ian Knowles and Janette Dalay Robertson , will be attending TARGET TO PATIENT 2026 (T2P26) on Monday 20th – Tuesday 21st April 2026 at the Hinxton Hall Conference Centre, Wellcome Genome Campus, Cambridge, UK. They look forward to meeting founders, investors and biotech leaders to discuss drug discovery, translational partnerships and life science investment opportunities. Feel free to catch them for a chat!
FROM DISCOVERY TO DISTRIBUTION
April 16, 2026
Pharmidex is pleased to announce that Martin Barrett , Head of Business Development, will be attending FROM DISCOVERY TO DISTRIBUTION – Making Pharmaceuticals 2026 on 21–22 April 2026 at the Coventry Building Society Arena, UK. Martin looks forward to meeting pharma innovators, formulation scientists, manufacturing leaders and strategic partners to discuss drug discovery, development, translational science, and end-to-end pharmaceutical solutions. If you’re attending, feel free to stop by for a chat and explore how Pharmidex can support your programmes from discovery through development.
April 15, 2026
Pharmidex will be attending Swiss Biotech Day 2026 on 4–5 May 2026 at the Congress Center Basel, Switzerland. We look forward to meeting founders, investors, biotech leaders and scientific partners to discuss drug discovery, translational development and strategic R&D opportunities. Feel free to catch us for a chat!
More Posts